Blood transcriptomic biomarkers in adult primary care patients with major depressive disorder undergoing cognitive behavioral therapy
An objective, laboratory-based diagnostic tool could increase the diagnostic accuracy of major depressive disorders (MDDs), identify factors that characterize patients and promote individualized therapy. The goal of this study was to assess a blood-based biomarker panel, which showed promise in adol...
Main Authors: | Redei, E E, Andrus, B M, Kwasny, M J, Seok, J, Cai, X, Ho, J, Mohr, D C |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198533/ |
Similar Items
-
Discovery of blood transcriptomic markers for depression in animal models and pilot validation in subjects with early-onset major depression
by: Pajer, K, et al.
Published: (2012) -
Effectiveness of Meta-Cognitive and Cognitive-Behavioral Therapy in Patients with Major Depressive Disorder
by: Ashouri, Ahmad, et al.
Published: (2013) -
Peripheral Biomarkers in Animal Models of Major Depressive Disorder
by: Carboni, Lucia
Published: (2013) -
Disorder-specific cognitive profiles in major depressive disorder and generalized anxiety disorder
by: Hendriks, Sanne M, et al.
Published: (2014) -
Temporal discounting in major depressive disorder
by: Pulcu, E., et al.
Published: (2014)